What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Conditions
Acute Coronary Syndrome · Myocardial Infarction · Atrial Fibrillation · Atrial Flutter · STEMI - ST Elevation Myocardial Infarction · NSTEMI - Non-ST Segment Elevation MI · Bleeding · Stroke · Stent Thrombosis · Embolism · Coronary Artery Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ASZ Aalst, Aalst, Belgium
RosseelUZ Antwerpen, Antwerp, Belgium
VandendriesscheImelda Ziekenhuis, Bonheiden, Belgium
DewildeUZ Brussel, Brussels, Belgium
VandelooZiekenhuis Oost-Limburg, Genk, Belgium
FerdinandeAZ Maria Middelares Gent, Ghent, Belgium
CornelisJan Yperman, Ieper, Belgium
Contact: Study coordinator (De Keyser)AZ Groeninge, Kortrijk, Belgium
Contact: Study coordinator (van mieghem, MD PhD)UZ Leuven, Leuven, Belgium
AdriaenssensAZ Delta, Roeselare, Belgium
DujardinNoordwest Ziekenhuisgroep, Alkmaar, Netherlands
HeestermansAmsterdam UMC, Amsterdam, Netherlands
Contact: Study coordinator (Simao Henriques, MD PhD)OLVG, Amsterdam, Netherlands
VinkCatharina Ziekenhuis, Eindhoven, Netherlands
VlaarTreant Zorggroep, Emmen, Netherlands
RuifrokZuyderland Ziekenhuis, Heerlen, Netherlands
Contact: Study coordinator (Van 't hof)Tergooi MC, Hilversum, Netherlands
PlompSt. Antonius Hospital, Nieuwegein, Netherlands
Contact: Study coordinator (Jurrien ten berg, MD PhD)Hagaziekenhuis, The Hague, Netherlands
SchotborghElisabeth Tweesteden Ziekenhuis, Tilburg, Netherlands
Magro
Study leads
Jurriën M ten Berg, Prof, MD
Principal Investigator
St. Antonius Hospital